300233.SZ
金城医药
SZSE · Basic Materials · C 制造业 · CN
CNY 13.07
−5.08%Margins
Gross margin
36.1%
EBITDA margin
14.7%
EBIT margin
4.0%
Net margin
2.4%
FCF margin
11.0%
1.8%
Return on equity
1.3%
Return on assets
2.9%
Return on invested capital
0.53x
Asset turnover
CNY 415.7M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026